Sichuan Hebang Biotechnology Hits Day Low Amid Price Pressure at CNY 2.94

Sichuan Hebang Biotechnology Co., Ltd. experienced a notable decline today, with the stock dropping by 3.25% as it reached an intraday low of CNY 2.94. This performance contrasts with the China Shanghai Composite, which saw a slight gain of 0.32% on the same day. Over the past week, Sichuan Hebang's stock has decreased by 1.65%, while the broader market index fell by 1.7%. However, the company has shown a significant increase of 25.21% over the past month, outperforming the Shanghai Composite, which declined by 0.47%. Year-to-date, Sichuan Hebang has achieved a return of 31.86%, compared to the index's modest 2.37% gain. Despite these short-term fluctuations, the company has faced challenges in its financial performance. Over the last five years, net sales have grown at an annual rate of 8.42%, but operating profit has seen a significant decline. The company has reported negative results for the last ten consecutive quarters, indicating ongoing financial difficulties. With a market capitalization of CNY 21,018 million, Sichuan Hebang remains a large-cap player in the Chemicals & Petrochemicals industry.